Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 4Unknown 2Suspended 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 9Neoplasm Metastasis 2Colorectal Neoplasms 2Recurrence 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Liver Diseases 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma 1Breast Neoplasms 1Advanced Gastric Cancer 1

Interventions

Fluorouracil 81Oxaliplatin 72Leucovorin 67Irinotecan 61Capecitabine 58Bevacizumab 57Cetuximab 43Folfox protocol 22Drug Therapy 22Neoadjuvant Therapy 19HMPL-013 17Colonoscopy 17regorafenib 15apatinib 11Panitumumab 11Chemotherapy, Adjuvant 11trifluridine tipiracil drug combination 10XELOX 10Laparoscopy 10IFL protocol 10sintilimab 9raltitrexed 9Radiotherapy 9Blood Specimen Collection 9Surveys and Questionnaires 8Surgical Procedures, Operative 8tislelizumab 7pembrolizumab 7Endoscopic Mucosal Resection 7Aspirin 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Colorectal Neoplasms × titanium silicide × Clear all
NCT02870153 2016-08-19

SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer

The First People's Hospital of Changzhou

Phase 2 Unknown
60 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00209651 2007-11-01

Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer

Hokkaido Gastrointestinal Cancer Study Group

Phase 2 Unknown
40 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡